6 Psychiatry Headlines You Missed in October 2025

From a new long-acting injectable for bipolar I disorder to a digital therapeutic targeting schizophrenia’s negative symptoms, October brought a wave of innovation in psychiatry. This month in review also highlights research exploring key differences in antidepressant side effects, novel adjunctive strategies for antidepressant tolerance, and how dietary habits may influence depression through the gut-brain axis. Rounding out the list, new trial data shed light on magnetic seizure therapy’s potential to match electroconvulsive therapy in efficacy while preserving cognition.